Christopher M De Fiebre

Title: Christopher M De Fiebre: Innovator in Nicotinic Receptor Research

Introduction

Christopher M De Fiebre is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of neuroscience, particularly in the study of nicotinic receptors in the brain. His innovative work has led to the development of a patent that addresses critical health issues related to receptor malfunction.

Latest Patents

Christopher M De Fiebre holds a patent for "Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines." This invention relates to compositions designed for treating conditions associated with defects or malfunctioning of nicotinic subtypes brain receptors. The compositions specifically target the alpha7 receptor subtype while minimizing activation of the alpha4beta2 or other receptor subtypes. This targeted approach has the potential to improve treatment outcomes for various neurological conditions.

Career Highlights

Christopher is affiliated with the University of Florida Research Foundation Inc., where he conducts research and develops innovative solutions in the field of neuroscience. His work has garnered attention for its potential applications in treating neurological disorders.

Collaborations

He has collaborated with esteemed colleagues, including Edwin M Meyer and William Reade Kem, to advance research in this area. Their combined expertise has contributed to the development of effective therapeutic strategies.

Conclusion

Christopher M De Fiebre's contributions to the field of neuroscience through his innovative patent highlight the importance of targeted therapies in treating neurological conditions. His work continues to pave the way for advancements in understanding and addressing receptor-related health issues.